 Norwood, MA, Aug. 12, 2021 GLOBE NEWSWIRE -- Corbus Pharmaceuticals Holdings, Inc. NASDAQ: CRBP Corbus or the Company, an immunology company, today provided corporate updates and reported financial results for the second quarter of 2021. 